|
Sign In to gain access to subscriptions and/or personal tools.
|
Clinical Trials, Vol. 2, No. 5,
423-435 (2005)
DOI: 10.1191/1740774505cn116oa
Design of the VA/NIH Acute Renal Failure Trial Network (ATN) study: intensive versus conventional renal support in acute renal failure
Paul M Palevsky
Renal Section, VA Pittsburgh Healthcare System and Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Room 7E123 (111F-U), VA Pittsburgh Healthcare System, University Drive Division, Pittsburgh, PA 15240, USA palevsky{at}pitt.edu
Theresa O'Connor
Jane Hongyuan Zhang
Cooperative Studies Program Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, USA
Robert A Star
National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
Mark W Smith
Health Economics Resource Center, VA Palo Alto Health Care System, Menlo Park, CA, USA
The optimal management of renal replacement therapy (RRT) in acute renal failure (ARF) is uncertain. The VA/NIH Acute Renal Failure Trail Network Study (ATN Study) tests the hypothesis that a strategy of intensive RRT will decrease 60-day all-cause mortality in critically ill patients with ARF. Dose separation between the two treatment arms is achieved by increasing the frequency of intermittent hemodialysis (IHD) and sustained low efficiency dialysis (SLED) treatments from three times per week to six times per week, and by increasing continuous venovenous hemodiafiltration (CVVHDF) effluent volume from 20 mL/kg/hr to 35 mL/kg/hr. In both treatment arms, subjects convert between IHD and CVVHDF or SLED as hemodynamic status changes over time. This strategy attempts to replicate the conversion between modalities of RRT that occurs in clinical practice. However, in order to implement this strategy, flexible criteria needed to be developed to provide a balance between the need for uniformity of treatment between groups and practitioner discretion regarding modality of RRT to maintain patient safety. In order to address safety and ethical issues similar to those raised by the Office of Human Research Protections in its review of the ARDS Network studies, a survey of practitioner practices was performed and observational data on the management of RRT in comparable critically ill patients with ARF managed outside of the research context is being collected prospectively. These data will help inform the study's DSMB and site IRB's of the relationship between the study's treatment arms and concurrent clinical practice.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. A. Desai, J. Baras, B. B. Berk, A. Nakajima, A. M. Garber, D. Owens, and G. M. Chertow
Management of Acute Kidney Injury in the Intensive Care Unit: A Cost-effectiveness Analysis of Daily vs Alternate-Day Hemodialysis
Arch Intern Med,
September 8, 2008;
168(16):
1761 - 1767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The VA/NIH Acute Renal Failure Trial Network
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
N. Engl. J. Med.,
July 3, 2008;
359(1):
7 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Crowley, G. M. Chertow, J. Vitale, T. O'Connor, J. Zhang, R. M.H. Schein, D. Choudhury, K. Finkel, A. Vijayan, E. Paganini, et al.
Lessons for Successful Study Enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study
Clin. J. Am. Soc. Nephrol.,
July 1, 2008;
3(4):
955 - 961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Mehta and J. Bouchard
Dialysis Dosage in Acute Kidney Injury: Still a Conundrum?
J. Am. Soc. Nephrol.,
June 1, 2008;
19(6):
1046 - 1048.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Chertow and S. S. Waikar
Toward the Promise of Renal Replacement Therapy
J. Am. Soc. Nephrol.,
May 1, 2008;
19(5):
839 - 840.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Koyner and P. T. Murray
Mechanical Ventilation and Lung-Kidney Interactions
Clin. J. Am. Soc. Nephrol.,
March 1, 2008;
3(2):
562 - 570.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pannu, S. Klarenbach, N. Wiebe, B. Manns, M. Tonelli, and for the Alberta Kidney Disease Network
Renal Replacement Therapy in Patients With Acute Renal Failure: A Systematic Review
JAMA,
February 20, 2008;
299(7):
793 - 805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Meyer and T. H. Hostetter
Uremia
N. Engl. J. Med.,
September 27, 2007;
357(13):
1316 - 1325.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. Teo, S. Demirjian, K. H. Meyer, E. Wright, and E. P. Paganini
Machine-generated bicarbonate dialysate for continuous therapy: a prospective, observational cohort study
Nephrol. Dial. Transplant.,
August 1, 2007;
22(8):
2304 - 2315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Overberger, M. Pesacreta, P. M. Palevsky, and for the VA/NIH Acute Renal Failure Trial Network
Management of Renal Replacement Therapy in Acute Kidney Injury: A Survey of Practitioner Prescribing Practices
Clin. J. Am. Soc. Nephrol.,
July 1, 2007;
2(4):
623 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Mehta
Comparing Dialysis Modalities for Critically Ill Patients: Are We Barking up the Wrong Tree?
Clin. J. Am. Soc. Nephrol.,
May 1, 2007;
2(3):
413 - 414.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dirkes and K. Hodge
Continuous Renal Replacement Therapy in the Adult Intensive Care Unit: History and Current Trends
Crit. Care Nurse,
April 1, 2007;
27(2):
61 - 80.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Waikar and J. V. Bonventre
Can We Rely on Blood Urea Nitrogen as a Biomarker to Determine When to Initiate Dialysis?
Clin. J. Am. Soc. Nephrol.,
September 1, 2006;
1(5):
903 - 904.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Liu, M. A. Matthay, and G. M. Chertow
Evolving Practices in Critical Care and Potential Implications for Management of Acute Kidney Injury
Clin. J. Am. Soc. Nephrol.,
July 1, 2006;
1(4):
869 - 873.
[Full Text]
[PDF]
|
 |
|
|